These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23963030)

  • 1. Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial.
    Belyaev O; Polle C; Herzog T; Munding J; Chromik AM; Meurer K; Tannapfel A; Bergmann U; Müller CA; Uhl W
    Scand J Surg; 2013; 102(3):164-70. PubMed ID: 23963030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD; Paik KY; Park IY; Yoo YK
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial bolus octreotide administration during Whipple procedure in patients with fragile pancreas: a novel technique for safer pancreaticojejunostomy.
    Konstadoulakis MM; Filippakis GM; Lagoudianakis E; Antonakis PT; Dervenis C; Bramis J
    J Surg Oncol; 2005 Mar; 89(4):268-72. PubMed ID: 15726611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin Versus Octreotide for Prevention of Postoperative Pancreatic Fistula: The PREFIPS Randomized Clinical Trial: A FRENCH 007-ACHBT Study.
    Gaujoux S; Regimbeau JM; Piessen G; Truant S; Foissac F; Barbier L; Buc E; Adham M; Fuks D; Deguelte S; Muscari F; Sulpice L; Vaillant JC; Schwarz L; Sa Cunha A; Muzzolini M; Dousset B; Sauvanet A;
    Ann Surg; 2024 Aug; 280(2):179-187. PubMed ID: 38662619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.
    Popiela T; Kedra B; Sierzega M; Gurda A
    Hepatogastroenterology; 2004; 51(59):1484-8. PubMed ID: 15362783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide Does Not Prevent Pancreatic Fistula Following Pancreatoduodenectomy in Patients with Soft Pancreas and Non-dilated Duct: A Prospective Randomized Controlled Trial.
    Kurumboor P; Palaniswami KN; Pramil K; George D; Ponnambathayil S; Varma D; Aikot S
    J Gastrointest Surg; 2015 Nov; 19(11):2038-44. PubMed ID: 26302879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
    Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA
    Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of early drain removal and triple-drug therapy to prevent pancreatic fistula after distal pancreatectomy.
    Adachi T; Kuroki T; Kitasato A; Hirabaru M; Matsushima H; Soyama A; Hidaka M; Takatsuki M; Eguchi S
    Pancreatology; 2015; 15(4):411-6. PubMed ID: 26073457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic parenchymal injection of ethanol and octreotide to induce focal pancreatic fibrosis in rats: Strategies to eliminate postoperative pancreatic fistula.
    Lee SH; Hong TH
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):81-85. PubMed ID: 29428110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy.
    Poon RT; Lo SH; Fong D; Fan ST; Wong J
    Am J Surg; 2002 Jan; 183(1):42-52. PubMed ID: 11869701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide hardens the pancreas.
    Foitzik T; Gock M; Schramm C; Prall F; Klar E
    Langenbecks Arch Surg; 2006 Apr; 391(2):108-12. PubMed ID: 16568326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.
    Lai EC; Lau SH; Lau WY
    Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T; Pratt WB; Callery MP; Vollmer CM
    J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of octreotide in the prevention of complications after pancreaticoduodenectomy in patients with soft pancreas and non-dilated pancreatic duct: A prospective randomized trial.
    El Nakeeb A; ElGawalby A; A Ali M; Shehta A; Hamed H; El Refea M; Moneer A; Abd El Rafee A
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):59-63. PubMed ID: 29428106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
    Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
    Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.